Opioid Use Disorder clinical trials
Showing 51–100 of 254 active trials. Describe your situation to see which ones you may be eligible for.
- Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.
- Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
- Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal
- Building Social and Structural Connections for the Prevention of Opioid Use Disorder Among Youth Experiencing Homelessness
- MethaLoad Dose-Finding Study
- Disclosure Intervention for People in Treatment for Opioid Use Disorder
- Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
- Food Insecurity and Eating Behavior Among Adults Receiving Buprenorphine or Methadone Maintenance Treatment: Pilot Study 2
- Combined Guanfacine and Mindfulness Meditation as an Adjunct to Buprenorphine Maintenance in Opioid Use Disorder
- E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- Social Functioning in Opioid Use Disorder
- Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
- LIFU for Treatment for Refractory Opioid Use Disorder
- A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
- Low-dose Buprenorphine Initiation for Opioid Use Disorder
- A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
- Vanderbilt Integrated Community TMS for Opioid Recovery
- rTMS as Add on Treatment for Substance Use Disorders
- Deep Brain Stimulation Effects In Patients With Opioid Use Disorder
- EXPANDED SCOPE for Parent Grant Entitled, "Peer Recovery Support Services for Individuals in Recovery Residences on MOUD"
- Autobiographical Memory in Opioid Use Disorder
- OUD (Opioid Use Disorder) Target Trial
- Divided or Single Exposure (DOSE) Study
- Long-Term Treatment of Opioid Use Disorder
- Neural Mechanisms of Meditation for Opioid-Treated Chronic Low Back Pain
- Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)
- Neuroplasticity in Maternal Opioid Use Disorder (OUD)
- Postpartum Intervention for Mothers With Opioid Use Disorders
- Mobile Platform for Optimizing Wellness and Engagement in Recovery
- Supporting Treatment Access and Recovery in COD
- Brain Training for Substance Use Disorders
- Wellcome Leap Psilocybin for OUD
- Standard Versus High Dose ED-Initiated Buprenorphine Induction
- A Study of Brenipatide in Participants With Opioid Use Disorder
- Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
- Smartphones for Opiate Addiction Recovery
- IMPOWR-ME Project 1: Trial of Yoga and Physical Therapy Onsite at Opioid Treatment Programs
- Individualized Adaptive Deep Brain Stimulation in Opioid Use Disorder
- Acetazolamide in Central Sleep Apnea Patients Using Medication for Opioid Use Disorder
- The Youth Opioid Recovery Support (YORS) Intervention
- Evaluating Buspirone to Treat Opioid Withdrawal
- Intervening on Opioid Use and Loneliness
- Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
- Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use
- Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
- Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
- Project STRONGER: Stepped Care for Opioid Use Disorder Treatment Engagement and Recovery
- Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women
- Kentucky Women's Justice Community Overdose Innovation Network - Phase II
- PRIDE III Prison Interventions and HIV Prevention Collaboration
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.